BioCentury
ARTICLE | Clinical News

Oros hydromorphone regulatory update

December 5, 2005 8:00 AM UTC

JNJ subsidiary Alza Corp. (Mountain View, Calif.) said it is considering its options for moving forward with its Oros hydromorphone to manage chronic pain after FDA said an additional trial would be ...